There was a trend toward reduction of median CTSH levels in the AD RNA sequencing analysis (see Fig E5, D)21; however, consistent with the lack of change in FLG mRNA levels, there was no correlation between filaggrin levels and CTSH in patients with AD (see Fig E5, E). Here, FLG is linked to Alzheimer disease.